New York State Teachers Retirement System cut its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 546,898 shares of the conglomerate’s stock after selling 33,045 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Danaher worth $125,540,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter worth $31,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher in the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC boosted its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the period. 79.05% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is owned by company insiders.
Analyst Ratings Changes
View Our Latest Research Report on DHR
Danaher Trading Up 0.7 %
Shares of NYSE:DHR opened at $203.56 on Friday. The company has a market cap of $147.03 billion, a P/E ratio of 38.55, a P/E/G ratio of 2.68 and a beta of 0.83. The stock’s 50-day moving average is $230.49 and its 200-day moving average is $250.28. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 EPS. Equities research analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- How to Invest in Blue Chip Stocks
- MicroStrategy’s 8% Preferred Stock: What Investors Should Know
- What is Short Interest? How to Use It
- Biotechs on the Brink: 2 Stocks With Huge Potential
- Using the MarketBeat Dividend Yield Calculator
- Silicon Valley’s Sleeping Giant? Intel’s Comeback in Focus
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.